Hypertension and glucose intolerance, determined in a random population sample (n = 2,475), showed a highly significant (P less than 0.001) association from the mildest levels of both conditions, independent of the confounding effects of age, sex, obesity, and antihypertensive medications. Summary rate ratios for hypertension were 1.48 (1.18-1.87) in abnormal tolerance and 2.26 (1.69-2.84) in diabetes compared with normal tolerance. Altogether, 83.4% of the hypertensives were either glucose-intolerant or obese--both established insulin-resistant conditions. Fasting and post-load insulin levels in a representative subgroup (n = 1,241) were significantly elevated in hypertension independent of obesity, glucose intolerance, age, and antihypertensive medications. The mean increment in summed 1- and 2-h insulin levels (milliunits per liter) compared with nonobese normotensives with normal tolerance was 12 for hypertension alone, 47 for obesity alone, 52 for abnormal tolerance alone, and 124 when all three conditions were present. The prevalence of concentrations (milliequivalents per liter) of erythrocyte Na+ greater than or equal to 7.0, K+ less than 92.5, and plasma K+ greater than or equal to 4.5 in a subsample of 59 individuals with all combinations of abnormal tolerance obesity and hypertension was compared with those in 30 individuals free of these conditions. Altogether, 88.1% of the former vs. 40.0% of the latter group presented at least one of these three markers of internal cation imbalance (P less than 0.001). We conclude that insulin resistance and/or hyperinsulinemia (a) are present in the majority of hypertensives, (b) constitute a common pathophysiologic feature of obesity, glucose intolerance, and hypertension, possibly explaining their ubiquitous association, and (c) may be linked to the increased peripheral vascular resistance of hypertension, which is putatively related to elevated intracellular sodium concentration.
M Modan, H Halkin, S Almog, A Lusky, A Eshkol, M Shefi, A Shitrit, Z Fuchs
Year: | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1982 | 1967 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 2 | 3 | 5 | 7 | 15 | 15 | 11 | 14 | 13 | 8 | 15 | 13 | 19 | 117 | 9 | 16 | 19 | 25 | 23 | 18 | 25 | 26 | 25 | 26 | 43 | 38 | 61 | 46 | 42 | 60 | 68 | 81 | 67 | 68 | 38 | 27 | 38 | 21 | 8 | 1 | 1 | 1177 |
Title and authors | Publication | Year |
---|---|---|
The metabolic syndrome and the heart—: a considered opinion
JG Leichman, VR Lavis, D Aguilar, CR Wilson, H Taegtmeyer |
Clinical Research in Cardiology | 2006 |
Women and Ischemic Heart Disease
AA Quyyumi |
Journal of the American College of Cardiology | 2006 |
A TELEOLOGICAL VIEW OF OBESITY, DIABETES AND HYPERTENSION
L Landsberg |
Clinical and Experimental Pharmacology and Physiology | 2006 |
Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice
R Rao, CM Hao, R Redha, DH Wasserman, OP McGuinness, MD Breyer |
Diabetologia | 2006 |
The metabolic syndrome and the heart—
JG Leichman, VR Lavis, D Aguilar, CR Wilson, H Taegtmeyer |
Clinical Research in Cardiology | 2006 |
Obesity-related cardiovascular disease: implications of obstructive sleep apnea
R Wolk, VK Somers |
Diabetes, Obesity and Metabolism | 2006 |
Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls
AK Ventura, E Loken, LL Birch |
Pediatrics | 2006 |
Development of the metabolic syndrome along the female biological life-path
M Esler, G Wiesner |
Journal of Hypertension | 2006 |
Metabolic Syndrome as a Predictor of Non-Dipping Hypertension
Z Tartan, H Uyarel, H Kasikcioglu, AT Alper, B Ozay, T Bilsel, M Gul, R Ozturk, N Cam |
The Tohoku Journal of Experimental Medicine | 2006 |
Insulin Resistance, Hyperinsulinemia, and Hypertension: An Epidemiologic Approach
PA Sarafidis, GL Bakris |
Journal of the CardioMetabolic Syndrome | 2006 |
La hipertensión arterial esencial, ¿es esencialmente metabólica?
AC Fort, JM Arribas, EA Ezquerra |
Medicina Clínica | 2006 |
Is there an estrogenic component in the metabolic syndrome?
S Starcke, G Vollmer |
Genes & Nutrition | 2006 |
Can PPARγ agonists have a role in the management of obesity-related hypertension?
VT Chetty, AM Sharma |
Vascular Pharmacology | 2006 |
Development of the metabolic syndrome along the female biological life-path:
M Esler, G Wiesner |
Journal of Hypertension | 2006 |
Disappearance of Glibenclamide-Induced Hypoglycemia in Wistar-Kyoto Rats
K Sakamoto, Y Yonoki, T Fujioka, M Matsumura, Y Mitsuta, M Sano, M Saito, T Nakahara, K Ishii |
Biological & Pharmaceutical Bulletin | 2006 |
The Metabolic Syndrome and Glucose Tolerance Status Deterioration Over 23-Year Follow-Up
RS Dankner, A Chetrit, U Goldbourt |
Diabetes care | 2006 |
The metabolic syndrome and cardiovascular disease
E Bonora |
Annals of Medicine | 2006 |
Enhanced sympathetic reactivity associates with insulin resistance in the young Zucker rat
P Ruggeri, A Brunori, CE Cogo, D Storace, FD Nardo, R Burattini |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2006 |
Chronic Hyperinsulinemia Enhances Adrenergic Vasoconstriction and Decreases Calcitonin Gene-Related Peptide-Containing Nerve-Mediated Vasodilation in Pithed Rats
S TAKATORI, Y ZAMAMI, M MIO, Y KUROSAKI, H KAWASAKI |
Hypertension Research | 2006 |
The Metabolic Syndrome: Time for a Critical Appraisal
R Kahn, J Buse, E Ferrannini, M Stern |
2006 | |
Obesity, sympathetic nervous system, and hypertension - are they connected?
AO Conrady |
2006 | |
Insulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
C Catena, R Lapenna, S Baroselli, E Nadalini, GL Colussi, M Novello, G Favret, A Melis, A Cavarape, LA Sechi |
The Journal of clinical endocrinology and metabolism | 2006 |
Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency
L Delasfuentes, P Soto, B Cupps, M Pasque, P Herrero, R Gropler, A Waggoner, V DAVILAROMAN |
Journal of Nuclear Cardiology | 2006 |